Page 5 - These Developments News Today

4.2.3 Wellness Hurts 4.3 Instrumentation and Automation 4.3.2 The Shrinking Machine. 4.4 Diagnostic Technology Development 4.4.2 POCT/Self Testing as a Disruptive Force 4.4.3 The Genetics Play - One Test for All Known Infections 4.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics 5. Molecular Dx - Infectious Disease Recent Developments Recent Developments- Importance and How to Use This Section Importance of These Developments Fusion Genomics to Assess NGS-Based Respiratory Tract In...

3.3.2 Bioinformatics Plays a Role 3.4 Diagnostic Technology Development 3.4.2 Impact of NGS on pricing 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 CGES Testing, A Brave New World 3.4.5 Biochips/Giant magnetoresistance based assay 4. Liquid Biopsy Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Liquid Biopsy NGS Panels - Diverse Test Claims CMS Colon Cancer Screening Me...

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic February 02, 2021 04:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitor...

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ...

Share this article Share this article ResearchAndMarkets.coms offering. Antimicrobial Resistance is creating new kinds of infections and "superbugs" that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market. We have identified the 6 Key Large Opportunities in this space and developed market forecasts.The publisher has looked at the technology picture too, giving you, plain language understanding of the different wa...

3.2.1 Whats Wrong with Microbiology 3.2.2 The Features Battleground of Infectious Disease Diagnostics 3.2.3 Multiplex vs. POC/Rapid 3.2.4 The Miracle of Genetics 3.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation 3.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing 3.2.7 Markers of Resistance 3.4. Antibiotic Resistance Recent Developments Importance of These Developments New method to test for infection resistance Qiagen launches AMR database Qiagen, Ares Genetics ...

Share this article Share this article ResearchAndMarkets.coms offering. The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians offices and elsewhere. And lets not forget the screening market, ...

Share this article Share this article ResearchAndMarkets.coms offering. This 2020 edition of the industry-standard report provides valuable information and insight. The report doesnt just look at market size. It examines key operational principles and industry best practices provided by industry veterans. Look at acquisition and divestiture opportunities. Revise pricing and service terms. Develop new service packaging and offerings. Consider integrated marketing programs. A growing market. Key ...

4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section Genetron Health Targeting Early Cancer Detection Pan-European Initiative to Build Tools for Sharing Genomic Data UK Government Unveils New Genomic Healthcare Strategy Foundation Medicine Liquid Biopsy Gets FDA Approval American Heart Association Develops Genetic Testing Guidelines Yourgene Health Gets CE Mark for Iona NIPT Test NorthShore Looks to Expand ...

Vizgen Launches With $14M Series A Financing SeqWell Raises $9M in Series B Round MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology Genomics Expects $271M In Proceeds Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts Bio-Rad Launches its Single Cell scATAC-Seq Solution Genomics Acquires Spatial Transcri...